Skip to main content
5 of 6 patients with CRIA (Cleavage-Resistant RIPK1-Induced Autoinflammatory) responded well to tocilizumab. @AmandaOmbrello #ACR19 @rheumnow
Jonathan Hausmann MD
Nov-11-2019
×